Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04154605 · ClinicalTrials.gov registry record · NA

ClariFix Rhinitis RCT

A NA study of Chronic Rhinitis, sponsored by Stryker Instruments.

Completed
Registry status
NA
Development phase
133
Enrollment target
1
Study location

NCT04154605 is a NA study of Chronic Rhinitis that has completed, run by Stryker Instruments. The registered enrollment target is 133 participants, above the 75-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (77% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04154605, a NA study of Chronic Rhinitis, has completed, sponsored by Stryker Instruments.

COMPLETED
Registry status
NA
Development phase
133 participants
Enrollment target
1
Study location

Study Summary

A randomized, sham-controlled, single-blind study of cryotherapy as a treatment for chronic rhinitis.

Conditions Studied

Interventions

  • DEVICE ClariFix cryotherapy
  • DEVICE Sham ClariFix cryotherapy

Study Locations (1)

Florida

  • ENT Associates of South Florida - Coral Springs

Trial Details

FieldValue
Enrollment Target 133 participants
Start Date 2019-11-05
Est. Completion 2025-01-19
Phase NA

Sponsor

Stryker Instruments

5 total trials

What the Registry Record Tells You About NCT04154605

The ClinicalTrials.gov registry entry for NCT04154605 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (77% higher). The listed sponsor is Stryker Instruments, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which ClariFix cryotherapy is the first listed.

NCT04154605 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04154605 about?

NCT04154605 is a clinical study titled "ClariFix Rhinitis RCT". A randomized, sham-controlled, single-blind study of cryotherapy as a treatment for chronic rhinitis.

What is the current status of trial NCT04154605?

This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2019-11-05. Estimated completion is 2025-01-19.

What conditions does trial NCT04154605 study?

This clinical trial studies the following conditions: Chronic Rhinitis.

What interventions are being tested in trial NCT04154605?

The interventions under investigation include: ClariFix cryotherapy (DEVICE), Sham ClariFix cryotherapy (DEVICE).

Who is sponsoring clinical trial NCT04154605?

This trial is sponsored by Stryker Instruments, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04154605 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.